KSI-3716
中文名称 | KSI-3716 |
---|---|
中文同义词 | 化合物 T11783 |
英文名称 | 3-acetyl-8-bromo-5-chloro-2-(4-chloroanilino)-1H-quinolin-4-one |
英文同义词 | 3-acetyl-8-bromo-5-chloro-2-(4-chloroanilino)-1H-quinolin-4-one;KSI-3716;4(1H)-Quinolinone, 3-acetyl-8-bromo-5-chloro-2-[(4-chlorophenyl)amino]-;KSI 3716,KSI3716 |
CAS号 | 1151813-61-4 |
分子式 | C17H11BrCl2N2O2 |
分子量 | 426.09 |
EINECS号 | |
相关类别 | |
Mol文件 | 1151813-61-4.mol |
结构式 | ![]() |
KSI-3716 性质
沸点 | 532.8±50.0 °C(Predicted) |
---|---|
密度 | 1.675±0.06 g/cm3(Predicted) |
储存条件 | Store at -20°C |
溶解度 | 二甲基亚砜:5 mg/ml(11.73 mM) |
酸度系数(pKa) | -2.74±0.20(Predicted) |
形态 | 固体 |
颜色 | 浅黄至卡其色 |
c-Myc
KSI-3716 blocks c-MYC/MAX from forming a complex with target gene promoters. KSI-3716 effectively blocks complex formation in a dose dependent manner (IC 50 =0.84 μM). c-MYC mediated transcriptional activity is inhibited by KSI-3716 at concentrations as low as 1 μM. The expression of c-MYC target genes, such as cyclin D2, CDK4 and hTERT, is markedly decreased. KSI-3716 exerts cytotoxic effects on bladder cancer cells by inducing cell cycle arrest and apoptosis.
Intravesical instillation of KSI-3716 at a dose of 5 mg/kg significantly suppresses tumor growth with minimal systemic toxicity.
安全信息
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024/04/30 | HY-12703 | KSI-3716 | 1 mg | 1590元 | |
2024/04/30 | HY-12703 | KSI-3716 KSI-3716 | 1151813-61-4 | 10mM * 1mLin DMSO | 3281元 |